Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-1,000
Closed -$13K 6066
2020
Q1
$13K Hold
1,000
﹤0.01% 5758
2019
Q4
$14K Buy
+1,000
New +$14.6K ﹤0.01% 6049
2019
Q1
Sell
-600
Closed -$7K 7236
2018
Q4
$7K Hold
600
﹤0.01% 6338
2018
Q3
$15K Sell
600
-500
-45% -$11.2K ﹤0.01% 6548
2018
Q2
$20K Sell
1,100
-700
-39% -$12.1K ﹤0.01% 6194
2018
Q1
$20K Buy
+1,800
New +$25.3K ﹤0.01% 6437
2017
Q3
Sell
-4,000
Closed -$80K 6988
2017
Q2
$80K Sell
4,000
-177,500
-98% -$3.1M ﹤0.01% 5073
2017
Q1
$2.74M Buy
+181,500
New +$1.99M ﹤0.01% 1782

Other funds holding OMER

Barclays's OMER Position: Q1 2026 in Review

Barclays reduced its Omeros (OMER) stake by 63% in Q1 2026, selling an estimated $890K and leaving 44,922 shares worth $474K. The position accounts for ﹤0.01% of the portfolio, ranked #3218.

Barclays first reported a position in OMER in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.07M in Q4 2025. 161 funds tracked by Wall St. Rank hold OMER as of Q1 2026.

  • Barclays held 44,922 shares of Omeros worth $474K as of Q1 2026.
  • Barclays sold 75,568 Omeros shares in Q1 2026, an estimated $890K.
  • Omeros made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3218 holding.
  • Barclays first reported a position in Omeros in Q2 2013 and has held it in 52 quarters since.
  • Barclays's Omeros position peaked at $2.07M in Q4 2025.
  • 161 funds tracked by Wall St. Rank held Omeros as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.